Home > Insider Trading > Filing (0000899243-21-040873)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1840229	Mink Therapeutics Inc.	INKT	Biological Products, (No Disgnostic Substances) (2836)	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1098972	Agenus Inc	3 Forbes Road Lexington MA 02421		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-10-19	1,400,000	$12.00	20,881,000	No	4	P	Direct
Common Stock	Disposition	2021-10-19	5,451,958	$0.00	26,332,958	No	4	C	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	C	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Convertible Promissory Note	Disposition	2021-10-19	5,451,958	$0.00	5,451,958	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2021-10-19	2022-07-01	No	4	C	Direct

Footnotes

The shares were purchased in this Issuer's initial public offering.
The shares were received upon the automatic conversion of a convertible promissory note issued to Agenus Inc. by the issuer upon completion of the Issuer's initial public offering. The conversion rate of the note was equal to the quotient obtained by dividing (i) the amount due on the date of conversion by (ii) 80% of the per share price of the common stock sold in the initial public offering.